Skip to main content

Will pharma face tougher FDA scrutiny by 2027?

Make a pick
zeitgeist· Science & Health

Will pharma face tougher FDA scrutiny by 2027?

Market overview

Will the FDA increase regulatory scrutiny over pharma and biotech by May 2027? This market tracks potential policy shifts impacting the industry.

Science & Health prediction market

Implied probability (Yes)
51%
Volume
$77,000
Closes
2027-05-04

Source: zeitgeist

More Science & Health markets

Browse all Science & Health markets →

No one's made a Conviction call on this yet. Be the first to call it →
Loading…